Loading...
Please wait, while we are loading the content...
Similar Documents
Development of an Androgen Receptor Inhibitor Targeting the N-Terminal Domain of Androgen Receptor for Treatment of Castration Resistant Prostate Cancer
| Content Provider | MDPI |
|---|---|
| Author | Ban, Fuqiang Leblanc, Eric Cavga, Ayse Huang, Chia-Chi Flory, Mark Zhang, Fan Chang, Matthew Morin, Hélène Lallous, Nada Singh, Kriti Gleave, Martin Mohammed, Hisham Rennie, Paul Lack, Nathan Cherkasov, Artem |
| Copyright Year | 2021 |
| Description | Prostate cancer patients undergoing androgen deprivation therapy almost invariably develop castration-resistant prostate cancer. Resistance can occur when mutations in the androgen receptor (AR) render anti-androgen drugs ineffective or through the expression of constitutively active splice variants lacking the androgen binding domain entirely (e.g., ARV7). In this study, we are reporting the discovery of a novel AR-NTD covalent inhibitor 1-chloro-3-[(5-([(2S)-3-chloro-2-hydroxypropyl]amino)naphthalen-1-yl)amino]propan-2-ol (VPC-220010) targeting the AR-N-terminal Domain (AR-NTD). VPC-220010 inhibits AR-mediated transcription of full length and truncated variant ARV7, downregulates AR response genes, and selectively reduces the growth of both full-length AR- and truncated AR-dependent prostate cancer cell lines. We show that VPC-220010 disrupts interactions between AR and known coactivators and coregulatory proteins, such as CHD4, FOXA1, ZMIZ1, and several SWI/SNF complex proteins. Taken together, our data suggest that VPC-220010 is a promising small molecule that can be further optimized into effective AR-NTD inhibitor for the treatment of CRPC. |
| Starting Page | 3488 |
| e-ISSN | 20726694 |
| DOI | 10.3390/cancers13143488 |
| Journal | Cancers |
| Issue Number | 14 |
| Volume Number | 13 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2021-07-12 |
| Access Restriction | Open |
| Subject Keyword | Cancers Oncology Castration Resistant Prostate Cancer Androgen Receptor Inhibitor N-terminal Domain Small Molecule Inhibitor Computer-aided Drug Design Ar Splice Variants |
| Content Type | Text |
| Resource Type | Article |